Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The value of patient-reported outcome measures for multiple sclerosis.

Literature DB >> 35876470

The value of patient-reported outcome measures for multiple sclerosis.

Marisa P McGinley¹, Brittany Lapin².

Abstract

Entities: Chemical

Mesh：

Year: 2022 PMID： 35876470 PMCID： PMC9326853 DOI： 10.1177/13524585221111675

Source DB: PubMed Journal: Mult Scler ISSN： 1352-4585 Impact factor: 5.855

Keyword Cloud
References

× No keyword cloud information.

9 in total

1. Patient-reported outcomes in the spotlight.

Authors:
Journal: Lancet Neurol Date: 2019-11 Impact factor: 44.182

2. Investigating the minimal important difference in ambulation in multiple sclerosis: a disconnect between performance-based and patient-reported outcomes?

Authors: Carolyn E Schwartz; Armon Ayandeh; Robert W Motl
Journal: J Neurol Sci Date: 2014-10-18 Impact factor: 3.181

3. Data mining for response shift patterns in multiple sclerosis patients using recursive partitioning tree analysis.

Authors: Yuelin Li; Carolyn E Schwartz
Journal: Qual Life Res Date: 2011-09-11 Impact factor: 4.147

4. Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?

Authors: Madeleine T King; Amylou C Dueck; Dennis A Revicki
Journal: Med Care Date: 2019-05 Impact factor: 2.983

5. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

Authors: Raju Kapoor; Pei-Ran Ho; Nolan Campbell; Ih Chang; Aaron Deykin; Fiona Forrestal; Nisha Lucas; Bei Yu; Douglas L Arnold; Mark S Freedman; Myla D Goldman; Hans-Peter Hartung; Eva Kubala Havrdová; Douglas Jeffery; Aaron Miller; Finn Sellebjerg; Diego Cadavid; Dan Mikol; Deborah Steiner
Journal: Lancet Neurol Date: 2018-03-12 Impact factor: 44.182

The value of patient-reported outcome measures for multiple sclerosis.

1. Patient-reported outcomes in the spotlight.

2. Investigating the minimal important difference in ambulation in multiple sclerosis: a disconnect between performance-based and patient-reported outcomes?

3. Data mining for response shift patterns in multiple sclerosis patients using recursive partitioning tree analysis.

4. Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?

5. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

6. Evaluating Individual Change With the Quality of Life in Neurological Disorders (Neuro-QoL) Short Forms.

7. Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.

8. Quality of life in adults with multiple sclerosis: a systematic review.

9. The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials.